mitochondria in the absence of a strongly reducing substrate because of the acceleration of NADP(H) oxidation by the mitochondrial energy-linked transhydrogenase (Hampson et al., 1984~) .
Glycine cleavage in the isolated perfused rat liver was investigated with a similar experimental rationale as in the mitochondrial studies discussed above (Hampson et al., 19846) . Maximal rates of [ l-'4C]glycine decarboxylation (e.g. 125 nmol/min per g) were attained at perfusate glycine concentrations approaching 10 mM. Infusion of metabolic substrates such as 3-hydroxybutyrate or octanoate inhibited the rate of glyciae cleavage by 33 and 50%, respectively. Metabolic conditions (e.g. NH,CI, 10 mM, plus pyruvate or lactate, 5 mM) which have been demonstrated to cause rapid consumption of intramitochondrial NADPH (Chamalaun & Tager, 1970; Siess et al., 1975) during urea synthesis caused an approximately three-fold increase in glycine decarboxylation by the perfused rat liver.
The stimulated rate of glycine decarboxylation and the synthesis of urea were inhibited nearly completely by propionate. It has been suggested that propionyl-CoA and/or methylmalonyl-CoA inhibit selected enzymic reactions in urea synthesis (Gruskay & Rosenberg, 1979; Coude et al., 1979; Martin-Requero et al., 1983) and it is likely that, in the present study, propionate inhibited urea synthesis, thus preventing the consumption of intramitochondrial PIADPH which in turn inhibited the glycine-cleavage reaction. Several laboratories have investigated the inhibitory effects of cysteamine on the glycine-cleavage reaction (e.g. see Y udkoff et al., 1981; Hayasaka & Tada, 1983) . In the present study the rapid rates of glycine decarboxylation observed under ureogenic conditions were inhibited nearly completely by co-infusion of cysteamine. The precise mechanism by which cysteamine inhibits glycine decarboxylation is presently under investigation.
In summary, our experimental approach has demonstrated that the hepatic glycine-cleavage system is regulated primarily by the oxidation-reduction state of the intramitochondrial NAD(H) and NADP(H) couples. Whether this type of regulation is physiologically important under normal metabolic conditions and/or contributes to pathological hyperglycinaemic states, remains to be demonstrated definitively .
A high-capacity system for branched-chain amino acid catabolism is needed to prevent the apparent toxic effects of these compounds and their metabolites seen in the human clinical condition known as maple syrup urine disease. On the other hand, catabolism must be tightly controlled, particularly when dietary protein intake is restricted, to assure continuous availability of these essential amino acids for protein synthesis. A large number of physiological conditions (e.g. starvation, diabetes, trauma) influence branched-chain amino acid metabolism, attesting to the importance of the regulatory mechanisms associated with their catabolism. Mechanisms that regulate blood levels of branched-chain amino acids may also be of considerable physiological importance, since one of these amino acids (leucine) inhibits protein degradation, stimulates protein synthesis and promotes insulin release. The possible therapeutic value of supplemental dietary branched-chain amino acids or their 2-0x0 acid analogues for the treatment of various disease states (e.g. muscular dystrophy, hepatic encephalopathy) is receiving attention.
Regulation of branched-chain amino acid catabolism is Vol. 14 achieved in large part by the branched-chain 2-0x0 acid dehydrogenase complex. This enzyme is responsible for the oxidative decarboxylation of all three 2-0x0 acids derived by transamination of the branched-chain amino acids. As with pyruvate dehydrogenase, the branched-chain 2-0x0 acid dehydrogenase is an intramitochondrial multi-enzyme complex subject to regulation by covalent modification (Fatania et al., 1981; Odessey, 1982; Paxton & Harris, 1982) . Specificity of branched-chain 2-0x0 acid dehydrogenase for 2-0x0 acids is much less than that of pyruvate dehydrogenase, suggesting that branched-chain 2-0x0 acid dehydrogenase may function not only in the catabolism of branchedchain amino acids but also in the catabolism of threonine and methionine (Paxton et al., 19866) and perhaps even pyruvate (Goodwin et al., 1986) . The branched-chain 2-0x0 acid dehydrogenase kinase, believed to be distinct from pyruvate dehydrogenase kinase, is an integral component of the branched-chain 2-0x0 acid dehydrogenase complex and is inhibited by branched-chain 2-0x0 acids (Lau et a/., 1982; Paxton & Harris, 1984a) , 2-chloro-4-methylpentanoate (Harris et al., 1982a) , phenylpyruvate (Paxton & Harris, 19846) , clofibric acid (Paxton & Harris, 19846) and dichloroacetate (Sans et al., 1980; Paxton & Harris, 19846) . Phosphorylation occurs on two serine residues of the u-subunit of the complex, with site-1 being more important than site-2 phosphorylation in modifying enzyme activity (Cook et al., 1984; Paxton et al., 1986a) . The branched-chain 2-0x0 acid dehydrogenase phosphatase also appears distinct from pyruvate dehydrogenase phosphatase (Damuni et al., 1984) .
Inhibition of branched-chain 2-0x0 acid dehydrogenase kinase by 2-chloro-4-methylpentanoate and 4-methyl-2-oxopentanoate 4-Methyl-2-oxopentanoate is a much more effective inhibitor than other 2-0x0 acids (Lau et al., 1982; Paxton & Harris, 1984~) . 2-Chloro-4-methyl-pentanoate, an analogue of 4-methyl-2-oxopentanoate and also a very potent and specific inhibitor of kinase activity (Harris et al., 1982a) , was synthesized at our request by Sandoz, Inc. It has proven to be useful for activation of the complex within intact cells (Davis & Lee, 1985; Toshima et al., 1985; Harris et al., 1986a) and for protecting branched-chain 2-0x0 acid dehydrogenase from phosphorylation by the kinase during enzyme extraction from freeze-clamped tissues (Harris et al., 1985) .
Activation of the branched-chain 2-0x0 acid dehydrogenase complex by broad specijicity phosphoprotein phosphatase Determination of the phosphorylation or activity state of branched-chain 2-0x0 acid dehydrogenase in tissue extracts requires a method for determination of the total activity of the complex. Activation of the complex can be achieved by endogenous phosphatase present in intact mitochondria (Wagenmakers et al., 1984; Block et al., 1985; Patston et al., 1986) . However, significant changes in activity state may occur during isolation of mitochondria and different physiological conditions may affect endogenous phosphatase activity. Consequently, this laboratory has used a purified, broad-specificity phosphoprotein phosphatase for activation of the complex in Triton X-100 extracts of freezeclamped tissues (Harris et al., 19826) . This phosphatase preparation has proven very useful as a tool for studying the phosphorylation sites of the purified enzyme and for determining the activity state of the enzyme in various tissues from rats of different nutritional and endocrine states (Gillim et al., 1983) .
The activity state of branched-chain 2-ox0 acid dehydrogenase in liver of rats,fed diets with different protein contents Rats fed a diet containing 8% protein exhibited restricted growth and extensive inactivation of hepatic branchedchain 2-0x0 acid dehydrogenase complex (Harris et a/., 1985) . Practically all of the enzyme was in the active state, i.e. non-phosphorylated, in animals maintained on the chow diet. Ninety-six hours on the low-protein diet decreased the active form of the enzyme to 13% of total activity. AS the dietary protein content was increased from 0% to 50% the proportion of enzyme in the active state also increased (Fig. 1) . Fifty per cent of the enzyme was in the active state with a diet containing about 20% protein. Almost all of the enzyme was active in the livers of rats on 30-50% protein diets, whereas almost all of the enzyme was inactive in rats on no protein or 8% protein diets.
A restriction of protein intake by feeding diets containing less than optimal amounts of protein was shown by Gillim et al. (1983) to result in inactivation of hepatic branchedchain 2-0x0 acid dehydrogenase. This finding, also observed by others (Hauschildt et al., 1982; Dixon & Harper, 1984; Patston et al., 1984) , is consistent with the need to conserve branched-chain amino acids for protein synthesis during periods of restricted protein intake. Protein intake beyond that needed for maximum growth maintains the active state of the complex, thereby providing a mechanism for the disposal of branched-chain amino acids in excess of that required for protein synthesis. The classical studies of McFarlane & von Holt (1969) and Wohlheuter & Harper (1970) oxidize branched-chain 2-0x0 acids in rats fed a low-protein diet, may now be explained on the basis of regulation of the activity state of the branched-chain 2-0x0 acid dehydrogenase complex by covalent modification.
Effect of starvation on the activity state of hepatic hranchedchain 2-0x0 acid dehydrogenase
Starvation for 48 h of rats previously maintained on chow (23% protein) diet has been found (Gillim et al., 1983; Harris et al., 1985 ; but for contradictory findings see Patston et al., 1986) to cause no significant change in the activity state of the hepatic enzyme, i.e. the branched-chain 2-0x0 acid dehydrogenase remains predominantly in the active state. In contrast, starvation of rats previously fed a low-protein (8%) diet, in which the hepatic enzyme is initially at a low-activity state, results in a dramatic increase in activity state of the enzyme (Harris et al., 1985) . Activation of the complex by starvation of rats previously fed a low-protein diet may be of physiological importance for gluconeogenesis from isoleucine and valine derived from endogenous protein.
Blood concentrations of branched-chain amino acids and 2-0x0 acids are decreased in rats fed low-protein diets (Adibi, 1976) . In contrast, increased blood levels of branchedchain amino acids and their corresponding 2-0x0 acids occur in starvation (Adibi, 1976) , presumably as a consequence of increased proteolysis of endogenous protein. These effects of restricted dietary protein intake and starvation on blood branched-chain 2-0x0 acid levels have been confirmed (G. Goodwin, unpublished work). The branchedchain amino acids, generated from dietary or endogenous proteins, are transaminated to 2-0x0 acids in extrahepatic tissues. The 2-0x0 acids are released in part into the blood, taken up by the liver, and oxidatively decarboxylated by the hepatic branched-chain 2-0x0 acid dehydrogenase complex (see Fig. 2 ; for a review see Harper et al., 1984) . Inactivation of the branched-chain 2-0x0 acid dehydrogenase complex observed in the protein-deficient state (Fig. 2c ) may be due to less inhibition of the kinase because of the reduced concentration of 2-0x0 acids. However, no change in activity state is observed upon starvation of chow-fed rats because, presumably, excess branched-chain 2-0x0 acids are supplied to the liver in both cases, i.e. by digestion of dietary protein in the fed state (Fig. 2a) or by mobilization of endogenous protein in the starved state (Fig. 26) . Similarly, starvation of rats fed low-protein diets promotes proteolysis of endogenous protein, giving rise to increased blood levels of branched-chain 2-0x0 acids which, in turn, inhibit the kinase and activate branched-chain 2-0x0 acid dehydrogenase.
Studies with isolated hepatocytes
Experiments with isolated hepatocytes prepared from chow-fed or starved rats and with rats fed a low-protein diet have been conducted to test the hypothesis that the 2-0x0 acids can regulate branched-chain 2-0x0 acid dehydrogenase activity state. Flux through the complex, as measured by decarboxylation of 3-methyl-2-oxo[ l-'4C]butanoate (the least potent kinase inhibitor of the 2-0x0 acids), was lowest in hepatocytes prepared from rats on the low-protein diet (Harris et al., 1985) . 2-Chloro-4-methylpentanoate, an inhibitor of the kinase, doubled the rate of 3-methyl-2-oxobutanoate decarboxylation by hepatocytes prepared from rats fed the low-protein diet (Table 1) but had no stimulating effect with hepatocytes prepared from chow-fed or 48-h-starved rats. Stimulation of the decarboxylation of 3-methyl-2-oxobutanoate by this kinase inhibitor suggests that branchedchain 2-0x0 acid dehydrogenase must be partially in the phosphorylated, inactive state in hepatocytes prepared from rats on the low-protein diet. Lack of an activating effect by the kinase inhibitor suggests that the enzyme is mainly in the active, dephosphorylated state in hepatocytes isolated from chow-fed or starved rats. This has been confirmed by measuring the activity state of the complex in cell-free extracts of hepatocytes (Harris et al., 1985) . Preservation of the in vivo activity state during isolation indicates that hepatocytes should be useful in identifying factors that affect covalent modification of the branched-chain 2-0x0 acid dehydrogenase. Indeed, results obtained with isolated hepatocytes provide additional evidence that blood branched-chain 2-0x0 acid concentration is an important determinant of the activity state of the enzyme (Table I) . Even though an excellent substrate for the complex, 4-methyl-2-oxopentanoate is as effective as 2-chloro-4-methyl-pentanoate in stimulating 3-methyl-2-oxobutanoate decarboxylation by hepatocytes isolated from rats fed a low-protein diet. Half-maximal activation by 4-methyl-2- Vol. 14 oxopentanoate occurred at a near physiological concentration of 20 p~. Stimulation of flux by 4-methyl-2-0x0-pentanoate was blocked by sodium fluoride, an inhibitor of branched-chain 2-0x0 acid dehydrogenase phosphatase, suggesting that stimulation was indeed due to inhibition of kinase activity followed by phosphatase activation of the complex (Table I) . 3-Methyl-2-oxopentanoate was also effective in stimulating decarboxylation of 3-methyl-2-oxobutanoate but less so than 4-methyl-2-oxopentanoate (Table I) , and neither compound stimulated flux with hepatocytes isolated from chow-fed or starved rats. Preincubation with 3-methyl-2-oxobutanoate did not have a significant effect on flux subsequently measured by the decarboxylation of this 2-0x0 acid (Table 1 ) nor on the decarboxylation of 4-methyl-2-oxopentanoate. Thus the order of effectiveness for stimulation of flux was: 2-chloro-4-methylpentanoate = 4-methyl-2-oxopentanoate > 3-methyl-2-oxopentanoate > 3-methyl-2-oxobutanoate (i.e. the same order of effectiveness of these compounds as inhibitors of branched-chain 2-0x0 acid dehydrogenase kinase). These findings support the hypothesis (Fig. 2) that portal blood concentrations of branched-chain 2-0x0 acids, especially 4-methyl-2-oxopentanoate, play an important role in regulation of the activity state of hepatic branched-chain 2-0x0 acid hydrogenase.
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